(Reuters) -Sensodyne toothpaste maker Haleon said on Thursday it expects high single-digit percentage growth in its operating profit from 2026, due to strength in key markets and expected costs cuts within its supply chain.
The consumer goods firm had earlier forecast adjusted operating profit growing “ahead of” the 4%-6% organic revenue growth at constant currency rate. Thursday’s more definite outlook sent its shares as much as 3.8% higher.
“We’ve delivered on the commitments we made since demerger and have established strong foundations as a standalone company,” Haleon CEO Brian McNamara said in a statement.
“We are now focused on unlocking the full potential of this company.”
The consumer healthcare group said it expects 800 million pounds ($1.07 billion) in gross productivity savings over the next five years.
The outlook was given by Haleon as part of its first ever Capital Markets Day, and comes a day after the company, which also makes Advil painkillers, said it was confident about meeting its 2025 targets despite U.S. demand uncertainty.
The company was formed in 2019 with the merger of GSK and Pfizer’s consumer healthcare businesses and later spun out and listed on the London Stock Exchange in 2022.
($1 = 0.7498 pounds)
(Reporting by Pushkala Aripaka in Bengaluru; Editing by Mrigank Dhaniwala and Leroy Leo)
Comments